Copyright & Attribution

This page sets out the copyright ownership of all content published on richstorm.co, the terms under which that content may be used by others, and the attribution standards applied to third-party sources referenced in RichStorm LLC's analysis.

 

Ownership of Original Content

All original content published on richstorm.co — including but not limited to articles, research reports, analytical frameworks, commentary, data presentations, charts, and any other written or visual materials produced by RichStorm LLC — is the exclusive intellectual property of RichStorm LLC.

All such content is protected under applicable United States and international copyright law. Unauthorised reproduction, distribution, republication, or commercial exploitation of any content from this website is strictly prohibited without the prior written consent of RichStorm LLC.

 

What You May Do

RichStorm LLC supports the sharing of ideas and the broader conversation around pharmaceutical investing and life sciences. The following uses of our content are permitted without prior written consent, provided the conditions below are met:

Sharing links — You may share links to any article or page on richstorm.co freely across any platform, including social media, newsletters, and professional communications.

Brief quotation — You may quote brief excerpts from RichStorm LLC content for purposes of commentary, criticism, education, or discussion, provided that the excerpt is clearly attributed to RichStorm LLC and accompanied by a direct link to the original source page.

Personal reference — You may save, print, or store copies of content for your own personal, non-commercial reference.

 

What You May Not Do

The following uses are not permitted without the prior written consent of RichStorm LLC:

Reproducing, republishing, or redistributing full articles, reports, or substantial portions of content from richstorm.co on any website, publication, newsletter, or platform

Using RichStorm LLC content for commercial purposes, including but not limited to paid newsletters, commercial publications, or monetised platforms

Presenting RichStorm LLC content as your own work or removing attribution to RichStorm LLC

Incorporating RichStorm LLC content into training datasets, artificial intelligence systems, or machine learning models without prior written consent

Translating, adapting, or creating derivative works from RichStorm LLC content without prior written consent

 

How to Attribute RichStorm LLC Content

When quoting or referencing content from richstorm.co in any publication, article, or communication, please use the following attribution format:

Source: RichStorm LLC, richstorm.co, [Article Title], [Publication Date]

Where possible, please include a hyperlink directly to the original article page. Attribution should appear adjacent to the quoted or referenced content, not only in a general footnote or bibliography.

 

Third-Party Sources & Data Attribution

RichStorm LLC's analysis draws exclusively on publicly available information. The following third-party sources are regularly referenced and retain their respective intellectual property rights. RichStorm LLC makes no claim of ownership over any data, filings, publications, or materials originating from these sources:

Regulatory & Government Sources United States Securities and Exchange Commission (SEC) — EDGAR database — sec.gov United States Food and Drug Administration (FDA) — fda.gov ClinicalTrials.gov — National Library of Medicine, U.S. Department of Health and Human Services U.S. Patent and Trademark Office (USPTO) — uspto.gov

Financial & Market Data Company investor relations materials, earnings releases, and annual reports Public financial data services including Yahoo Finance, FinanceCharts, and similar platforms ETF provider materials including State Street Global Advisors (XBI), BlackRock iShares (IBB), ARK Invest (ARKG), and VanEck (BBH)

Medical & Scientific Sources Peer-reviewed academic journals and publicly available research publications Medical conference abstracts and presentations (ASCO, ADA, ASH, EASL, ESMO, and others) Publicly available clinical trial protocols and results

News & Industry Sources Publicly available news articles, industry publications, and press releases

All third-party sources are referenced for informational and analytical purposes only. Reference to any third-party source does not imply endorsement of RichStorm LLC by that source, nor endorsement of that source by RichStorm LLC.

 

Use of Artificial Intelligence Tools

RichStorm LLC uses artificial intelligence tools as part of its research and content development process. All analysis, editorial judgment, and intellectual direction reflected in content published on richstorm.co is the responsibility of RichStorm LLC. AI tools are used to assist with research synthesis, drafting, and structure — not to replace the analytical framework and perspective that RichStorm LLC applies to publicly available information.

All content published on richstorm.co is reviewed, directed, and published under the editorial responsibility of RichStorm LLC.

 

Republication & Licensing Requests

If you wish to republish, license, translate, or otherwise use RichStorm LLC content beyond the permitted uses described above, please contact us through the contact page at richstorm.co/contact. Please include a description of the intended use, the specific content you wish to use, and the platform or publication in which it would appear. RichStorm LLC will respond to all reasonable requests in good faith.

 

Updates to This Statement

This Copyright & Attribution statement may be updated periodically to reflect changes in our content, practices, or applicable law. The date of the most recent update is indicated at the top of this page. Continued use of richstorm.co following any update constitutes your acceptance of the revised statement.